[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
News From the Centers for Disease Control and Prevention
May 10, 2000

Adoption of Perinatal Group B Streptococcal Disease Prevention Recommendations by Prenatal-Care Providers—Connecticut and Minnesota, 1998

JAMA. 2000;283(18):2384-2385. doi:10.1001/jama.283.18.2384-JWR0510-4-1

MMWR. 2000;49:228-232

2 tables omitted

Group B streptococcal (GBS) infections are the leading bacterial cause of serious neonatal disease in the United States.1 In 1996, in collaboration with the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists, CDC issued consensus guidelines for preventing perinatal GBS disease.2-4 These guidelines recommend using either a screening-based or a risk-based strategy to identify women who should receive intrapartum antimicrobial prophylaxis. To assess adoption of the GBS disease prevention guidelines, the Connecticut and Minnesota state health departments surveyed prenatal-care providers during January-April 1998. This report presents the survey findings, which indicate that most prenatal-care providers in Connecticut and Minnesota have adopted perinatal GBS disease prevention policies and that strategy choice may vary by state and provider type.